Another treatment option is available to treat SUI. Uromedica has developed ACT®, adjustable continence therapy for women and ProACT™, adjustable continence therapy for men. ACT and ProACT are minimally invasive, adjustable treatment options designed to help patients reclaim their continence.
Minimally invasive procedure designed to treat male patients who have stress urinary incontinence (SUI) as a result of radical prostatectomy (RP) or transurethral resection of the prostate (TURP). Commercially available in the U.S.A.
Minimally invasive procedure designed to treat female patients who have stress urinary incontinence (SUI) resulting from intrinsic sphincter deficiency (ISD).
Caution – The Uromedica ACT system is an INVESTIGATIONAL DEVICE, LIMITED BY FEDERAL (OR UNITED STATES) LAW TO INVESTIGATIONAL USE. The ACT System is not available for sale in the United States. The Uromedica ACT system has received European CE Mark approval, Canadian licensing, and is listed on the Australian Register of Therapeutic Goods for treatment of stress urinary incontinence and is available for sale in Europe, Canada and Australia.
WHAT MAKES PROACT DIFFERENT?
ProACT balloons are designed to be placed using a sheath via two small incisions compared to an invasive open procedure.
No surgery required to make adjustments. ProACT can be adjusted postoperatively in an office setting. This allows the physician to fine tune the device to best meet each individual patient’s continence needs.
Patient ease of use is very important that’s why ProACT is a passive therapy. No patient manipulation of the device is required, including for voiding to occur.
If an adverse event occurs requiring explant, ProACT can be easily removed in 5-10 minutes in your physician’s office. Alternative therapies require an additional invasive surgery to remove. No complicated removal is necessary for ProACT.
Important Safety Info: The potential risks with the ProACT implant procedure include perforation, migration, erosion, infection, and other risks. If an infection occurs at the implant site, it can be treated with antibiotics. If a more serious side effect occurs (e.g., perforation, migration, erosion), ProACT can be completely removed in an office setting. See ProACT Safety Information Sheet for further safety information.Your Doctor is your best source for further information on the risks and benefits of ProACT.
For any additional questions contact Uromedica.
WHAT OUR PATIENTS HAVE TO SAY:
BOB // POST PROSTATE REMOVAL
“Bob had his prostate removed in April of 2011 due to prostate cancer. As a result, Bob was left with incontinence for seven years and was using 5-6 pads per day.
After putting ProACT to the test, Bob now uses a light pad after the device was adjusted three times. As a result of meeting his individual continence needs, Bob has gotten his life back thanks to the ProACT therapy.
Results may vary. Not all patients respond the same. Bob received no compensation for this testimonial.
The potential risks with the ProACT implant procedure include perforation, migration, erosion, infection, and other risks. If an infection occurs at the implant site, it can be treated with antibiotics. If a more serious side effect occurs (e.g., perforation, migration, erosion), ProACT can be completely removed in an office setting. See ProACT Safety Information Sheet for further safety information. Your Doctor is your best source for further information on the risks and benefits of ProACT.
GET IN TOUCH
Information provided to us may be used for regulatory reporting purposes but will not otherwise be shared outside of Uromedica. We will respond to your comments or inquiry via email or telephone. Our email response will include your first and last name and will repeat your message to us, which could include personal information about your health. If this is a cause for concern, please call instead of submitting this form.